Slovacchia - slovacco - ŠÚKL (Štátny ústav pre kontrolu liečiv)

entermed b.v. edisonstraat 22 8912 leeuwarden holandsko -

Slovacchia - slovacco - ŠÚKL (Štátny ústav pre kontrolu liečiv)

entermed b.v. edisonstraat 22 8912 leeuwarden holandsko -

Unione Europea - slovacco - EMA (European Medicines Agency)

regeneron ireland designated activity company (dac) - cemiplimab - karcinóm, šquamózna bunka - antineoplastické činidlá - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Unione Europea - slovacco - EMA (European Medicines Agency)

immunocore ireland limited - tebentafusp - uveal neoplasms - antineoplastické činidlá - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.

Unione Europea - slovacco - EMA (European Medicines Agency)

argenx - efgartigimod alfa - myasthenia gravis - imunosupresíva - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.

Slovacchia - slovacco - myHealthbox

bayer ag - kvapalný koncentrát - propamocarb 530 g/l; fosetyl-al 310 g/l

Slovacchia - slovacco - myHealthbox

bayer ag - kvapalný koncentrát - propamocarb 530 g/l; fosetyl-al 310 g/l

Unione Europea - slovacco - EMA (European Medicines Agency)

mylan s.a.s. - docetaxel - head and neck neoplasms; carcinoma, non-small-cell lung; adenocarcinoma; prostatic neoplasms; breast neoplasms - antineoplastické činidlá - liečba rakoviny prsníka, špeciálne formy rakoviny pľúc (small-cell lung cancer), rakoviny prostaty, rakoviny žalúdka alebo rakovina hlavy a krku.

Unione Europea - slovacco - EMA (European Medicines Agency)

eckert ziegler radiopharma gmbh - yttrium (90y) chloride - radionuklidové zobrazovanie - diagnostické rádiofarmaká - používať len na rádioaktívne označovanie nosičových molekúl, ktoré boli špecificky vyvinuté a povolené na rádioaktívne značenie týmto rádioaktívnym povlakom. radiopharmaceutical predchodcu - nie sú určené na priame použitie v prípade pacientov.

Slovacchia - slovacco - ŠÚKL (Štátny ústav pre kontrolu liečiv)

roche slovensko - interferón alfa-2a - 44 - cytostatica